All Stocks
pharma

MRK — Merck & Co. Inc.

Conviction23
Congress 90d1
Insider 90d0
Markets0
Lobbying7
Contracts0
CountryUS

MRK

Merck & Co. Inc.

pharma
23thin · 1 src Bullish1 source agree
🏛 Congress

Congressional trades

Last 90 days
1 buy0 sell1 legislator
  • buy Maria Elvira Salazar · Aug 19, 2026

Prediction markets

No prediction markets reference this stock.

Lobbying filings

Last 2 years
  • FORBES-TATE$80K · 2026 first_quarter
    CHMMANTRD
  • TIBER CREEK HEALTH STRATEGIES, INC.$50K · 2026 first_quarter
  • FORBES-TATE$50K · 2026 first_quarter
    AGRANIBUDMARNAT
  • TIBER CREEK GROUP$50K · 2026 first_quarter
    HCRMMMTRD
  • W STRATEGIES, LLC$50K · 2026 first_quarter
    MMM
  • BALLARD PARTNERS$80K · 2026 first_quarter
  • B HALL STRATEGIES, LLC$30K · 2026 first_quarter
    PHA

Country exposure

Domicile · not revenue geography

Approximated from company domicile — not revenue-by-geography.This panel maps the ticker to a single country using the company's registered domicile, a static lookup. It does not reflect where the company actually earns revenue or carries operational exposure (e.g. a US-domiciled chipmaker may have most of its real exposure in Taiwan or China).

🇺🇸 United States82/100
Posture: riskView United States

Insider activity

No insider transactions filed in the last 90 days.

Federal contracts

No federal contract awards matched this company.

0e1e144